Cited by 195Advanced Glycation End Products researchDialysis and Renal Disease ManagementChronic Kidney Disease and Diabetes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Advanced glycation end products and mortality in hemodialysis patients

Open access

Schwedler, Susanne B., Metzger, Thomas, Schinzel, Reinhard, Wanner, Christoph·2002·Kidney International

DOI 10.1046/j.1523-1755.2002.00423.x

Open this paper in CoChat — free account

Abstract

Background Advanced glycation and oxidation end products (AGEs) cause oxidative stress and trigger cytokine driven inflammatory reactions in vitro. The net effects on markers of inflammation and acute phase proteins in vivo as well as their influence on survival in hemodialysis patients are unknown.Methods We conducted a cross-sectional study in 312 stable hemodialysis patients and analyzed the interrelationships of AGEs and C-reactive protein (CRP) and their predictive effect on all-cause as well as cardiovascular mortality. Mortality was monitored prospectively over a period of 32 months. AGEs were determined by measuring total serum fluorescent AGEs (AGE-fl) and Nepsilon-(carboxymethyl)-lysine (CML).Results The levels of AGE-fl, CML and CRP were 3.2-, 3.8- and 10-fold higher as compared to healthy controls. AGE-fl and CML levels correlated significantly with each other but not with CRP or serum albumin. Patients with high (above median values) AGE-fl or CML levels (109 x 103 AU and 1.4 microg/mL, respectively) had a significant better survival than those with low (below median values) AGE-fl or CML levels. Patients with high CRP levels (above 7.7 mg/L = median value) had a better survival than those with low CRP (below median value) when AGE-fl or CML levels were high in parallel.Conclusions In contrast to in vitro data and to current hypotheses, the presence of high serum AGEs, as measured by AGE-fl and CML, were not linked to increased mortality. Statistically, high serum AGEs partly overcame the negative impact of the acute phase response on mortality in hemodialysis patients. Whether the benefit of high serum AGEs is an epiphenomenon or reflects a better nutritional support needs further studies.

Integrity signals

Registry

Crossref · 10.1046/j.1523-1755.2002.00423.x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., & Wanner, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00273.x · Cited by 1,531
Self-citation
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z. H., Skolnik, E. Y., DELANEY, V. B., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 922
The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
Fu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822
Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.
Schleicher, E. D., Wagner, E., & Nerlich, A. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119180 · Cited by 714
Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy
Thornalley, P. J. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02054-3 · Cited by 591
C-Reactive Protein in the Arterial Intima
Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J. L., Köenig, W., Schmitz, G., Hombach, V., & Torzewski, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2094 · Cited by 585

Show all 38 references

Sorted by citations

Items 101–194 of 194

The mechanism by which dietary AGEs are a risk to human health is via their interaction with RAGE: Arguing against the motion
Heizmann, C. W. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600284 · Cited by 32
Formation and elimination of pyrraline in the Maillard reaction in a saccharide–lysine model system
Liang, Z., Li, L., Fu, Q., Zhang, X., Xu, Z., & Li, B. (2015) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7376 · Cited by 31
Skin Autofluorescence Predicts Cardiovascular Mortality in Patients on Chronic Hemodialysis
Kimura, H., Tanaka, K., Kanno, M., Watanabe, K., Hayashi, Y., Asahi, K., Suzuki, H., Sato, K., Sakaue, M., Terawaki, H., et al. (2014) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12160 · Cited by 31
Relationship of Skin Autofluorescence to Cardiovascular Disease in Japanese Hemodialysis Patients
Tanaka, K., Katoh, T., Asai, J., Nemoto, F., Suzuki, H., Asahi, K., Sato, K., Sakaue, M., Miyata, T., & Watanabe, T. (2009) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00782.x · Cited by 31
Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature
Pliakogiannis, T., Trpeski, L., Taşkapan, H., Shah, H., Ahmad, M., Fenton, S., Bargman, J. M., & Oreopoulos, D. G. (2006) · International Urology and Nephrology · doi:10.1007/s11255-006-9142-1 · Cited by 31
Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
Kaňková, K. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108006034 · Cited by 30
Effects of hemodialysis period on levels of blood trace elements and oxidative stress
Koca, T., Berber, A., Koca, H. B., Demir, T. A., & Köken, T. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0310-3 · Cited by 30
Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients
Nongnuch, A., & Davenport, A. (2015) · Nephrology · doi:10.1111/nep.12519 · Cited by 29
Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies
Berdowska, I., Matusiewicz, M., & Fecka, I. (2023) · Molecules · doi:10.3390/molecules28237742 · Cited by 26
[Is C-reactive protein a marker of inflammation?].
Dupuy, A., Terrier, N., Senécal, L., Morena-Carrere, M., Leray, H., Canaud, B., & Cristol, J. (2003) · PubMed · Cited by 27
AGEs and Cardiovascular Diseases in Patients With End-Stage Renal Diseases
Nishizawà, Y., Koyama, H., & Inaba, M. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2011.10.019 · Cited by 27
New Methods and Technologies for Measuring Uremic Toxins and Quantifying Dialysis Adequacy
Vanholder, R. C., Boelaert, J., Glorieux, G., & Eloot, S. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12331 · Cited by 27
Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study
Sutherland, W. H. F., de Jong, S. A., & Walker, R. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg484 · Cited by 27
The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
Meertens, J. H. J. M., Nienhuis, H. L. A., Lefrandt, J. D., Schalkwijk, C. G., Nyyssönen, K., Ligtenberg, J. J. M., Smit, A. J., Zijlstra, J. G., & Mulder, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160893 · Cited by 27
Oxidative Stress: An Accomplice to Uremic Toxicity?
Mircescu, G. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.015 · Cited by 26
Skin-Autofluorescence Is an Independent Predictor of Graft Loss in Renal Transplant Recipients
Hartog, J. W. L., Groß, S., Oterdoom, L. H., van Ree, R. M., de Vries, A. P. J., Smit, A. J., Schouten, J. P., Nawroth, P. P., Gans, R. O. B., van Son, W. J., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e31819d3173 · Cited by 26
Oxidative stress and uremia
Floccari, F., Aloisi, C., Crascì, E., Sofi, T., Campo, S., Tripodo, D., Criseo, M., Frisina, N., & Buemi, M. (2005) · Medicinal Research Reviews · doi:10.1002/med.20028 · Cited by 26
Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study
Ebert, H., Lacruz, M. E., Kluttig, A., Simm, A., Greiser, K. H., Tiller, D., Kartschmit, N., & Mikolajczyk, R. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110815 · Cited by 24
Metabolic syndrome and associated chronic kidney diseases: Nutritional interventions
Pasupulati, A. K., Chitra, P. S., & Reddy, G. B. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9268-2 · Cited by 22
Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence.
Oleniuc, M., Secara, I., Onofriescu, M., Hogas, S. M., Voroneanu, L. E., Siriopol, D. C., & Covic, A. C. (2011) · PubMed Central · Cited by 23
The Low AGE Diet: A Neglected Aspect of Clinical Nephrology Practice?
Uribarri, J., & He, C. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000381315 · Cited by 23
Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis
Wang, C., Wang, Y.-C., Wang, G., Shen, M., Chang, Y.-L., Liou, S.-Y., Chen, H.-C., & Chang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147771 · Cited by 23
Glycated proteins in nutrition: Friend or foe?
Šebeková, K., & Šebeková, K. B. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.11.012 · Cited by 23
Removal of Urea, β2-Microglobulin, and Indoxyl Sulfate Assessed by Absorbance and Fluorescence in the Spent Dialysate During Hemodialysis
Lauri, K., Arund, J., Holmar, J., Tanner, R., Kalle, S., Luman, M., & Fridolin, I. (2019) · ASAIO Journal · doi:10.1097/mat.0000000000001058 · Cited by 23
Maillard Reaction of Proteins and Advanced Glycation End Products (AGEs) in Food
Henle, T. (2008) · Wiley eBooks · doi:10.1002/9780470430101.ch2g · Cited by 24
High plasma pentosidine level is accompanied with cardiovascular events in hemodialysis patients
Furuya, R., Kumagai, H., Miyata, T., Fukasawa, H., Isobe, S., Kinoshita, N., & Hishida, A. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0573-3 · Cited by 22
Hemodialysis Removes Uremic Toxins That Alter the Biological Actions of Endothelial Cells
Zafeiropoulou, K., Bita, T., Polykratis, A., Karabina, S., Vlachojannis, J. G., & Katsoris, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030975 · Cited by 22
Republished paper: Arterial stiffness in chronic kidney disease: causes and consequences
Chue, C. D., Townend, J., Steeds, R. P., & Ferro, C. J. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.184879rep · Cited by 22
Associations of Serum Levels of Advanced Glycation end Products with Nutrition Markers and Anemia in Patients with Chronic Kidney Disease
Kratochvílová, M., Zakiyanov, O., Kalousová, M., Kříha, V., Zima, T., & Tesař, V. (2011) · Renal Failure · doi:10.3109/0886022x.2010.541581 · Cited by 21
Serum Levels of the Advanced Glycation End Products Nε-Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension
Busch, M., Franke, S., Wolf, G., Rohde, R. D., & Stein, G. (2008) · Nephron Clinical Practice · doi:10.1159/000127838 · Cited by 20
Skin and Plasma Autofluorescence During Hemodialysis: A Pilot Study
Graaff, R., Arsov, S., Ramsauer, B., Koetsier, M., Sundvall, N., Engels, G. E., Sikole, A., Lundberg, L., Rakhorst, G., & Stegmayr, B. G. (2013) · Artificial Organs · doi:10.1111/aor.12205 · Cited by 19
Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients
Badiou, S., Thiébaut, R., Aurillac-Lavignolle, V., Dabis, F., Laporte, F., Cristol, J., & Mercié, P. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.05.007 · Cited by 19
Effect of Diabetes Mellitus on Protein–Energy Wasting and Protein Wasting in End‐Stage Renal Disease
Noori, N., & Kopple, J. D. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00705.x · Cited by 20
Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals
Stam, F., Schalkwijk, C. G., van Guldener, C., ter Wee, P. M., & Stehouwer, C. D. A. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi309 · Cited by 18
Backen, Altern, Diabetes: eine kurze Geschichte der Maillard‐Reaktion
Hellwig, M., & Henle, T. (2014) · Angewandte Chemie · doi:10.1002/ange.201308808 · Cited by 18
The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease
Krane, V., & Wanner, C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_11.23 · Cited by 17
Self-citation
Influence of Icodextrin on Plasma and Dialysate Levels of N ∊ -(Carboxymethyl)Lysine and N ∊ -(Carboxyethyl)Lysine
Konings, C. J. A. M., Schalkwijk, C. G., SANDE, F. M. V. D., Leunissen, K. M. L., & Kooman, J. P. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500616 · Cited by 17
Evolving Pandemic Diabetic Nephropathy
Friedman, E. A. (2010) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10005 · Cited by 16
Online Hemodiafiltration
Laecke, S. V., Wilde, K. D., & Vanholder, R. C. (2006) · Artificial Organs · doi:10.1111/j.1525-1594.2006.00266.x · Cited by 16
“NEPP” Peritoneal Dialysis Regimen has Beneficial Effects on Plasma Cel and 3-DG, but not Pentosidine, CML, and MGO
le Poole, C. Y., van Ittersum, F. J., Valentijn, R. M., Teerlink, T., Lindholm, B., ter Wee, P. M., & Schalkwijk, C. G. (2011) · Peritoneal Dialysis International · doi:10.3747/pdi.2010.00101 · Cited by 15
Biocatalytic Reversal of Advanced Glycation End Product Modification
Kim, N. Y., Goddard, T. N., Sohn, S., Spiegel, D. A., & Crawford, J. M. (2019) · ChemBioChem · doi:10.1002/cbic.201900158 · Cited by 15
ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES
Kobalava, J. D., Kotovskaya, Y. V., Вадимовна, В. С., Soloveva, A. E., & Амирбегишвили, И. М. (2014) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2014-10-1-83-91 · Cited by 14
Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis
Jiang, J., Zhang, Y., Chen, J., Yang, X., Mei, C., Xiong, F., Shi, W., Zhou, W., Liu, X., Sun, S., et al. (2021) · American Journal of Nephrology · doi:10.1159/000512385 · Cited by 13
The Pathophysiology of Uremia
Meyer, T. W., & Hostetter, T. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10053-3 · Cited by 13
Olmesartan Medoxomil Is Associated with Decreased Plasma AGEs, Pentosidine, andN-(Epsilon)-Carboxymethyl-Lysine Levels in Hemodialysis Patients
Honda, H., Hosaka, N., Aoshima, Y., Hirai, Y., Michihata, T., & Akizawa, T. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2011.628726 · Cited by 12
Uremic Toxicity
Chmielewski, M. S., Heimbürger, O., Stenvinkel, P., & Lindholm, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00004-7 · Cited by 12
Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis
El-Saeed, G. S. M., Fadel, F. I., Elshamaa, M. F., Galal, R. E. E., Elghoroury, E. A., Nasr, S. A., Thabet, E. H., & Abdelrahman, S. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1077317 · Cited by 12
Transition Metals and Other Forms of Oxidative Protein Damage in Renal Disease
Monnier, V. M., Nemet, I., Sell, D. R., & Weiss, M. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_2 · Cited by 11
Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients
Bossola, M., & Tazza, L. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12345 · Cited by 11
The association of non-invasive skin autofluorescence measurements with cardiovascular and all-cause mortality in hemodialysis patients: a meta-analysis
Varikasuvu, S. R., Sulekar, H., Aloori, S., & Thangappazham, B. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02543-6 · Cited by 11
Assessment of the Concentration of Advanced Glycation End Products in Traditional Chinese Foods
Xu, R., Lu, Y., Kang, S., & Liu, L. (2016) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.12811 · Cited by 10
Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
Assiri, A. M. A., Kamel, H. F. M., & ALrefai, A. A. (2018) · Medical Sciences · doi:10.3390/medsci6020038 · Cited by 10
Peritoneal dialysis solutions and patient survival: does wishing make it so?
Bargman, J. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl460 · Cited by 10
The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients
Braschi, S., Geoffrion, M., Nguyen, A., Gaudreau, Y., & Milne, R. W. (2006) · Diabetologia · doi:10.1007/s00125-006-0217-4 · Cited by 9
Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate
Ramsauer, B., Engels, G. E., Graaff, R., Sikole, A., Arsov, S., & Stegmayr, B. G. (2017) · BMC Nephrology · doi:10.1186/s12882-016-0418-0 · Cited by 9
Advanced Glycation Endproducts (AGEs)
Rabbani, N., & Thornalley, P. J. (2012) · Wiley eBooks · doi:10.1002/9781118424032.ch19 · Cited by 9
Comparing Changes in Plasma and Skin Autofluorescence in Low-Flux versus High-Flux Hemodialysis
Ramsauer, B., Engels, G. E., Arsov, S., Hadimeri, H., Sikole, A., Graaff, R., & Stegmayr, B. G. (2015) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000434 · Cited by 8
Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration
Nakayama, M., Yoshimura, K., Maruyama, Y., Numata, M., Hosoya, T., & Izumi, G. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh198 · Cited by 8
A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis
Aroni, A., Detopoulou, P., Presvelos, D., Kostopoulou, E., Ioannidis, A., Panoutsopoulos, G. I., Zyga, S., Kosmidis, G., Spiliotis, B. E., & Gil, A. P. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168893 · Cited by 7
HbA1c and survival in maintenance hemodialysis patients with diabetes in Han Chinese population
Li, X., Xu, X., Liu, J., Yang, J., Fang, L., Miao, L., Di, J., & He, X. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0764-4 · Cited by 7
The Pathophysiology of Uremia
Abramowitz, M. K., Meyer, T. W., & Hostetter, T. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00018-2 · Cited by 7
Atherosklerose und Urämie: Die Bedeutung nicht-traditioneller Risikofaktoren
Hörl, W. H. (2003) · Wiener klinische Wochenschrift · doi:10.1007/bf03040320 · Cited by 7
Uremic Toxicity
Vanholder, R. C., & Glorieux, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79135-9.00002-1 · Cited by 7
RENAL RESEARCH INSTITUTE SYMPOSIUM: Efforts to Determine the Role of Oxidant Stress in Dialysis Outcomes
Handelman, G. J. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16105.x · Cited by 6
CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: How to Reconcile Conventional and Altered Risk Factor Patterns in Dialysis Patients
Kopple, J. D. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00362.x · Cited by 6
The effects of hemodialysis on the cardiovascular system
Pallister, Z. S., & Chung, J. (2024) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2024.10.001 · Cited by 5
Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries
Shoji, T., Tsubakihara, Y., Nakai, S., & Nishizawà, Y. (2008) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2008.01.005 · Cited by 5
Examination of skin autofluorescence for the determination of glycation end-products in patients on chronic hemodialysis
Голубев, Р. В., Papayan, G. V., Glazunova, A. A., Коростелева, Н. Ю., Петрищев, Н. Н., & Smirnov, A. V. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh201688665-72 · Cited by 5
Protein-Energy Wasting as a Risk Factor of Morbidity and Mortality in Chronic Kidney Disease
Kovesdy, C. P., & Kalantar‐Zadeh, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00012-6 · Cited by 5
Lipid Peroxidation, Advanced Glycation end Products and Antioxidant Status in Patients on Dialysis.
Stefańska, A., Sypniewska, G., Donderski, R. Ł., & Manitius, J. (2005) · Europe PMC (PubMed Central) · Cited by 4
Cardiovascular Complications in Renal Failure: Implications of Advanced Glycation End Products and Their Receptor RAGE
Koyama, H., & Nishizawà, Y. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_13 · Cited by 4
Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study
Bayliss, G. P., Weinrauch, L. A., Gleason, R. E., Lee, A. T., & D’Elia, J. A. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft116 · Cited by 4
Predictive Factors of Cardiovascular Disease in Patients on Maintenance Hemodialysis
Danış, R., Özmen, Ş., Akın, D., Çelik, F., & Yazanel, O. (2008) · Dialysis & Transplantation · doi:10.1002/dat.20189 · Cited by 2
Glycemic Control: Risk Factors, Quality of Life, Workforce Participation, and Mortality Among US Adults with Type 2 Diabetes
Davila, E. P. (2010) · doi:10.25148/etd.fi10041607 · Cited by 2
Cardiovascular risk and its determinants in high risk patients
Gerrits, E. G. (2012) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Visible fluorescence of biological fluids as a renal failure marker: New integrative approach
Kuznetsov, A. I., Frorip, A., Kozlova, J., Nagirnyi, V., Ots-Rosenberg, M., Romet, I., & Sünter, A. (2015) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545815500303 · Cited by 1
Hypochlorous Acid and 3,4-Dihydroxyphenylalanine Increase the Formation of Serum Protein Lipofuscin-Like Fluorophores In Vitro
Sutherland, W. H. F., de Jong, S. A., & Walker, R. J. (2005) · Renal Failure · doi:10.1081/jdi-200049544 · Cited by 1
Advanced glycation end products in hemodialysates as fluorescent and optical absorption markers of patients mortality
Kuznetsov, A. I., Frorip, A., Maiste, A., Ots-Rosenberg, M., Sünter, A., Sablonin, J., & Vasil'chenko, J. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2083585 · Cited by 1
The uremic syndrome and pathophysiology of chronic renal failure
Hörl, W. H. (2004) · Springer eBooks · doi:10.1007/978-1-4020-2275-3_3 · Cited by 1
[Management of micro-inflammation in uremia].
Massy, Z. A., & Choukroun, G. (2003) · PubMed · Cited by 1
Regarding “Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study”
Meerwaldt, R., & Zeebregts, C. J. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.04.033 · Cited by 1
Should we reconsider the advanced glycation end product issue in hemodialysis patients?
Schwedler, S. B., & Wanner, C. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.02.186
Self-citation
Vascular stiffness in chronic kidney disease
Townend, J., & Ferro, C. J. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199592548.003.0111
Arterial Stiffness in Chronic Kidney Disease
Salvi, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-40501-8_7
Chapter 2: Transition Metals and Other Forms of Oxidative Protein Damage in Renal Disease
Monnier, M., Nemet, I., Sell, R. D., & Weiss, F. (2011)
Methylglyoxal, the glyoxalase pathway and advanced glycation endproducts in type 2 diabetes and cardiovascular disease
Hanssen, N. M. J. (2015) · doi:10.26481/dis.20150520nh
In Reply
Wagner, Z., Wagner, L. J., & Wittmann, I. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.003
Evaluating atherosclerosis prevalence via coronary calcium in executives with normal LDL levels in the US: a cohort study–the clear protocol
Ratrout, B. M., Katamesh, B. E., Vincent, A., Hurt, R. T., Bonnes, S. L. R., Adusumalli, J., Lawson, D. K., Schroeder, D. R., Verness, C. D., & Croghan, I. T. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094899
Rôle des toxines urémiques dans le déséquilibre lésion/régénération de l'endothélium
Jourde‐Chiche, N. (2010) · doi:10.70675/1502bcf9za703z4993zb367z52c4569092a9
Biomarqueurs du risque cardiovasculaire en insuffisance rénale chronique
Bargnoux, A. (2010) · theses.fr (ABES) · doi:10.70675/ecc36defz77e9z46dcz9538z508a5061b8b8
Effet du régime alimentaire sur les teneurs en Produits de Maillard dans le plasma, l'urine et les fèces de sujets sains
Fernandez, G. S. (2011) · theses.fr (ABES) · doi:10.70675/6c619d81zca71z4c88zbfb3z5f70714d414c
Monoclonal Antibody-Based ELISA Quantification of Serum Methylglyoxal-Derived Hydroimidazolone-1
Nojima, J., Tasaka, M., Fujigaki, H., Sugiura, S., Yamamoto, Y., Enomoto, T., Matuo, Y., & Saito, K. (2026) · Diagnostics · doi:10.3390/diagnostics16162593
Pathomics (Final Report)
USDOE, Turteltaub, K., Ascher, M., Langlois, R., Fodor, I., Kercher, J., McLaughlin, K., Nelson, D. O., Colston, W. (., & Milanovich, F. (2006) · doi:10.2172/1036867
Establishing a high risk CKD cohort: cross-sectional analysis and early outcomes
Stringer, S. J. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)

Authors: Schwedler, S. B., Metzger, T., Schinzel, R., & Wanner, C.
Affiliations: University of Würzburg (DE)
Corresponding author: Wanner, Christoph
ORCID: Schinzel, Reinhard
Wanner, Christoph
Venue: Kidney International
Publisher: Elsevier BV
Published: 2002-07
Volume: 62
Issue: 1
Pages: 301-310
ISSN: 0085-2538 (ISSN-L)
DOI: 10.1046/j.1523-1755.2002.00423.x
OpenAlex: W2013180282
Cited by: 195
References: 38
Citations by year: 2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 6 · 2017: 2 · 2016: 6 · 2015: 12 · 2014: 9 · 2013: 10 · 2012: 12
FWCI: 10.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4907 d)
Locations: Kidney International (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords: advanced glycation end products, hemodialysis patients, mortality, C-reactive protein, carboxymethyllysine, acute phase response, inflammation, cardiovascular mortality, all-cause mortality, survival
MeSH terms: Adult, Aged, Aged, 80 and over, Aspirin, C-Reactive Protein, Female, Renal Dialysis, Humans, Lysine, Male, Middle Aged, Serum Albumin, Survival Rate, Glycation End Products, Advanced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advanced glycation end products and mortality in hemodialysis patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks